NCT06593314View on ClinicalTrials.gov

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

NARecruitingINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

March 15, 2026

Study Completion Date

June 15, 2027

Conditions

Heart FailureDiabetes

Interventions

BEHAVIORAL

Message with EchoGo

This alert will inform the provider that the patient has subclinical HFpEF

BEHAVIORAL

Standard Message

This alert will inform the provider of guideline directed treatment options for patients with diabetes to prevent heart failure.

Trial Locations (1)

75235

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER

NCT06593314 - Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter